John L. Marshall, MD - Proactive Safety Management Strategies to Extend Survival for Patients With Metastatic CRC

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Busting Brain Myths: TikTok's Viral Neuroscientist 11 min · 24 Sep 2026 · Today with David McCullagh

We Investigated the Christian "Scam" Fronted by Tim Tebow 1h 17m · 24 Sep 2026 · Pablo Torre Finds Out

Trump threatens Iran in fiery UN speech. What's next? 14 min · 24 Sep 2026 · The Excerpt

Why Grit Isn’t Always Enough with Angela Duckworth 1h 3m · 24 Sep 2026 · The Curiosity Shop with Brené Brown and Adam Grant

Trump Wakes Up to Nightmare With Xi 17 min · 24 Sep 2026 · The MeidasTouch Podcast

Stress: The Science of Chilling Out 37 min · 24 Sep 2026 · Science Vs

Report any issue

Source

Recorded09 Aug 2024

Publisherc.answersincme.com ↗

Handlerec:766025

Show notes

Please visit answersincme.com/ZVJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in the management of metastatic colorectal cancer (mCRC) discusses treatment strategies to enhance patient outcomes during later-line therapy. Upon completion of this activity, participants should be better able to: Identify guideline recommendations for later-line treatments for patients with mCRC; Describe recent evidence for later-line treatments for patients with mCRC, including evidence informing treatment sequencing; and Review evidence-based, patient-centered approaches to manage adverse events for patients with mCRC receiving later-line treatment.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in